Corporate Profile

We are a clinical stage biotechnology company developing first-in-class antibody product candidates focused on unmet medical needs in inflammation.

More
ANAB (Common Stock) $23.90 Stock is Down 0.1 (0.42%)02/28/17 11:50 a.m. ET
Stock chart for: ANAB.O.  Currently trading at $23.90 with a 52 week high of $26.41 and a 52 week low of $15.17.
Data provided by Nasdaq. Minimum 15 minutes delayed.




Upcoming Events


  |   |   |   |   |